970 related articles for article (PubMed ID: 30793936)
41. Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1.
Kim AY; Shim HJ; Shin HM; Lee YJ; Nam H; Kim SY; Youn HS
Int Immunopharmacol; 2018 Apr; 57():172-180. PubMed ID: 29518743
[TBL] [Abstract][Full Text] [Related]
42. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
43. A critical role for the TLR4/TRIF pathway in allogeneic hematopoietic cell rejection by innate immune cells.
Xu H; Yan J; Zhu Z; Hussain LR; Huang Y; Ding C; Bozulic LD; Wen Y; Ildstad ST
Cell Transplant; 2013; 22(12):2367-80. PubMed ID: 23146386
[TBL] [Abstract][Full Text] [Related]
44. TRIM8 Negatively Regulates TLR3/4-Mediated Innate Immune Response by Blocking TRIF-TBK1 Interaction.
Ye W; Hu MM; Lei CQ; Zhou Q; Lin H; Sun MS; Shu HB
J Immunol; 2017 Sep; 199(5):1856-1864. PubMed ID: 28747347
[TBL] [Abstract][Full Text] [Related]
45. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
Kim EJ; Lee SM; Suk K; Lee WH
Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
[TBL] [Abstract][Full Text] [Related]
46. Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4.
Milanesi S; Verzola D; Cappadona F; Bonino B; Murugavel A; Pontremoli R; Garibotto G; Viazzi F
J Cell Physiol; 2019 Jul; 234(7):10868-10876. PubMed ID: 30536556
[TBL] [Abstract][Full Text] [Related]
47. Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ.
Stokes JA; Corr M; Yaksh TL
Pain; 2013 May; 154(5):733-742. PubMed ID: 23489833
[TBL] [Abstract][Full Text] [Related]
48. TRIF, and TRIF-interacting TLRs differentially modulate several adenovirus vector-induced immune responses.
Appledorn DM; Patial S; Godbehere S; Parameswaran N; Amalfitano A
J Innate Immun; 2009; 1(4):376-88. PubMed ID: 20375595
[TBL] [Abstract][Full Text] [Related]
49. Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus.
Biancardi VC; Stranahan AM; Krause EG; de Kloet AD; Stern JE
Am J Physiol Heart Circ Physiol; 2016 Feb; 310(3):H404-15. PubMed ID: 26637556
[TBL] [Abstract][Full Text] [Related]
50. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
51. The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.
Leichtle A; Hernandez M; Pak K; Webster NJ; Wasserman SI; Ryan AF
BMC Immunol; 2009 Aug; 10():45. PubMed ID: 19656404
[TBL] [Abstract][Full Text] [Related]
52. Direct Actions of AT
Sparks MA; Rianto F; Diaz E; Revoori R; Hoang T; Bouknight L; Stegbauer J; Vivekanandan-Giri A; Ruiz P; Pennathur S; Abraham DM; Gurley SB; Crowley SD; Coffman TM
Hypertension; 2021 Feb; 77(2):393-404. PubMed ID: 33390039
[TBL] [Abstract][Full Text] [Related]
53. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells.
Yanagibashi T; Nagai Y; Watanabe Y; Ikutani M; Hirai Y; Takatsu K
Immunol Lett; 2015 Jan; 163(1):22-31. PubMed ID: 25448706
[TBL] [Abstract][Full Text] [Related]
54. Aging and contribution of MyD88 and TRIF to expression of TLR pathway-associated genes following stimulation with Porphyromonas gingivalis.
Shaik-Dasthagirisaheb YB; Huang N; Weinberg EO; Shen SS; Genco CA; Gibson FC
J Periodontal Res; 2015 Feb; 50(1):89-102. PubMed ID: 24862405
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.
Kaiser WJ; Sridharan H; Huang C; Mandal P; Upton JW; Gough PJ; Sehon CA; Marquis RW; Bertin J; Mocarski ES
J Biol Chem; 2013 Oct; 288(43):31268-79. PubMed ID: 24019532
[TBL] [Abstract][Full Text] [Related]
56. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
57. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
59. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
60. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
Ebrahimian T; Sairam MR; Schiffrin EL; Touyz RM
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1481-8. PubMed ID: 18676690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
